Galvin Legal is launching an investigation on behalf of investors who may have suffered losses investing with John Correnti. If you suffered losses investing with John Correnti, then Galvin Legal may be able to help you recover your losses in a Financial Industry Regulatory Authority (“FINRA“) arbitration claim. John Correnti (CRD# 5319471) As of JuneRead More
Galvin Legal is launching an investigation on behalf of investors who suffered losses investing in Oncolytics Biotech at the recommendation of their financial advisor. If you suffered losses investing in Oncolytics Biotech, then Galvin Legal may be able to help you recover your losses in a Financial Industry Regulatory Authority (“FINRA“) arbitration claim against theRead More
